中华皮肤科杂志
中華皮膚科雜誌
중화피부과잡지
Chinese Journal of Dermatology
2013年
5期
362-364
,共3页
潘月飞%付萌%高继鑫%李巍%乔洪江%李春英%李承新%王刚%高天文
潘月飛%付萌%高繼鑫%李巍%喬洪江%李春英%李承新%王剛%高天文
반월비%부맹%고계흠%리외%교홍강%리춘영%리승신%왕강%고천문
目的 比较不同类型药疹患者血清学及细胞中颗粒溶素表达差异.方法 酶联免疫吸附试验(ELISA)和流式细胞仪分别检测7例中毒性表皮坏死松解症、5例Stevens-Johnson综合征进展期患者、8例多形红斑药疹患者、8例发疹型药疹患者及11例健康人血清及外周血T细胞中颗粒溶素的表达水平.利用SPSS17.0进行统计学分析,两组均数比较采用随机或配对t检验,3组间比较采用ANOVA分析.结果 中毒性表皮坏死松解症和Stevens-Johnson综合征急性期患者血清颗粒溶素水平为(0.196±0.079) μg/L,明显高于发疹型药疹患者[(0.022±0.003) μg/L]和健康对照[(0.013±0.005) μg/L],F=3.926,P<0.05,但与多形红斑患者[(0.058±0.004) μg/L]相比差异无统计学意义.Stevens-Johnson综合征患者和中毒性表皮坏死松解症患者表达颗粒溶素的CD8+T细胞比例为(3.400±0.754)%,多形红斑组为(0.600±0.250)%,发疹型药疹组和健康对照组分别为(0.342±0.251)%和(0.054±0.024)%,4组间差异有统计学意义,F=11.4,P<0.01.结论 颗粒溶素在中毒性表皮坏死松解症、Stevens-Johnson综合征患者中表达水平较高,可能对该病急性期的鉴别诊断及预后评价具有潜在的应用价值.
目的 比較不同類型藥疹患者血清學及細胞中顆粒溶素錶達差異.方法 酶聯免疫吸附試驗(ELISA)和流式細胞儀分彆檢測7例中毒性錶皮壞死鬆解癥、5例Stevens-Johnson綜閤徵進展期患者、8例多形紅斑藥疹患者、8例髮疹型藥疹患者及11例健康人血清及外週血T細胞中顆粒溶素的錶達水平.利用SPSS17.0進行統計學分析,兩組均數比較採用隨機或配對t檢驗,3組間比較採用ANOVA分析.結果 中毒性錶皮壞死鬆解癥和Stevens-Johnson綜閤徵急性期患者血清顆粒溶素水平為(0.196±0.079) μg/L,明顯高于髮疹型藥疹患者[(0.022±0.003) μg/L]和健康對照[(0.013±0.005) μg/L],F=3.926,P<0.05,但與多形紅斑患者[(0.058±0.004) μg/L]相比差異無統計學意義.Stevens-Johnson綜閤徵患者和中毒性錶皮壞死鬆解癥患者錶達顆粒溶素的CD8+T細胞比例為(3.400±0.754)%,多形紅斑組為(0.600±0.250)%,髮疹型藥疹組和健康對照組分彆為(0.342±0.251)%和(0.054±0.024)%,4組間差異有統計學意義,F=11.4,P<0.01.結論 顆粒溶素在中毒性錶皮壞死鬆解癥、Stevens-Johnson綜閤徵患者中錶達水平較高,可能對該病急性期的鑒彆診斷及預後評價具有潛在的應用價值.
목적 비교불동류형약진환자혈청학급세포중과립용소표체차이.방법 매련면역흡부시험(ELISA)화류식세포의분별검측7례중독성표피배사송해증、5례Stevens-Johnson종합정진전기환자、8례다형홍반약진환자、8례발진형약진환자급11례건강인혈청급외주혈T세포중과립용소적표체수평.이용SPSS17.0진행통계학분석,량조균수비교채용수궤혹배대t검험,3조간비교채용ANOVA분석.결과 중독성표피배사송해증화Stevens-Johnson종합정급성기환자혈청과립용소수평위(0.196±0.079) μg/L,명현고우발진형약진환자[(0.022±0.003) μg/L]화건강대조[(0.013±0.005) μg/L],F=3.926,P<0.05,단여다형홍반환자[(0.058±0.004) μg/L]상비차이무통계학의의.Stevens-Johnson종합정환자화중독성표피배사송해증환자표체과립용소적CD8+T세포비례위(3.400±0.754)%,다형홍반조위(0.600±0.250)%,발진형약진조화건강대조조분별위(0.342±0.251)%화(0.054±0.024)%,4조간차이유통계학의의,F=11.4,P<0.01.결론 과립용소재중독성표피배사송해증、Stevens-Johnson종합정환자중표체수평교고,가능대해병급성기적감별진단급예후평개구유잠재적응용개치.
Objective To compare the cellular and serum expression levels of granulysin among patients with different types of drug eruption.Methods Blood samples were collected from 7 patients with toxic epidermal necrolysis (TEN),5 patients with acute Stevens-Johnson syndrome (SJS),8 patients with erythema multiforme,8 patients with exanthematic drug eruption,and 11 healthy controls.Flow cytometry and enzyme-linked immunosorbent assay (ELISA) were performed to quantify the protein expression of granulysin in peripheral blood T cells and sera from these subjects,respectively.Data were processed by the SPSS17.0 software,and differences in these parameters were analyzed by one-way analysis of variance and independent or paired sample t-test.Results The serum level of granulysin in patients with TEN or acute SJS was significantly higher than that in those with exanthematic drug eruption and healthy controls ((0.196 ± 0.079) μg/L vs.(0.022 ± 0.003) μg/L and (0.013 ±0.005) μg/L,F =3.926,P < 0.05),but similar to that in those with erythema multiforme ((0.058 ± 0.004) μg/L,P >0.05).Significant differences were observed in the proportion of CD8+ T cells expressing granulysin in peripheral blood mononuclear cells (PBMCs) between patients with TEN or acute SJS,erythema multiforme,exanthematic drug eruption,and healthy controls ((3.400 ± 0.754)% vs.(0.600 ± 0.250)% vs.(0.342 ± 0.251)% vs.(0.054 ±0.024)%,F =11.4,P < 0.01).Conclusions Granulysin is highly expressed in patients with TEN and SJS,which may have potential value for their differential diagnosis and prognosis evaluation at acute phase.